Skip to content
Riskpilot
← Back to search
Sign in
Get full access
KenMed Invest 4 AB
AB
Active
Org 5592868227
Economic activity was not specified by tax authority
· NACE 0000
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
KenMed Invest 4 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−4
−7
−6
−8
−7
Depreciation & amort.
−0
−0
−0
—
—
EBIT
−4
−7
−6
−8
−7
Net financials
192
192
192
240
240
Profit before tax
188
185
186
232
233
Tax
−0
−0
−0
—
—
Net profit
188
185
186
232
233
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
253
255
254
298
326
Equity
213
215
213
257
285
Long-term debt
0
0
0
—
—
Short-term debt
40
40
40
40
40
Total debt
40
40
40
40
40
Financial ratios
5-year trend
EBITDA margin
-729400.0%
This company
15.8%
Market median
-4616556% vs market
2021
2025
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
2021
2025
Return on equity
81.7%
This company
18.4%
Market median
+344% vs market
2021
2025
Net profit margin
23300500.0%
This company
8.1%
Market median
+287660394% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-04-30
View
PDF
More on KenMed Invest 4 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot